Engrail Therapeutics

Engrail Therapeutics

Acquiring, developing and commercializing transformative medicines.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD856m—1.3b (Dealroom.co estimates Mar 2024.)
San Diego California (HQ)
Authorizing premium user...